Aoli Biotechnology

Recent Finacing

Pre-Series A

Recent Raise

Undisclosed

Aoli Bio develops Macoral® oral delivery platform for large-molecule biologics (peptides, potential antibodies), advancing oral peptide pipelines including a GLP‑1 candidate, with preclinical large‑animal data, lab facilities, and collaborations.